ClinicalTrials.gg
RecruitingNCT05668182Updated Feb 9, 2026

A Case Series: TRUMATCH Graft Cage for Segmental Long Bone Defects

An observational study in Tibia Fracture, Humerus Fracture and Femoral Fracture, sponsored by University of California, San Diego. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-09.

Sponsored by University of California, San Diego · Observational

How we know

From the registry’s dates

  • Started Jun 2021; still recruiting 5 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
5
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 50 studies in Tibial Fractures with a site in United States — 15 open to participants now, 18 under way, 3 of them phase 3. Tibial Fractures · United States.

Planned enrollment
10th of 12
5 · median 97
Started
2021
with 4 others
Observational
12 of 50
2 open now
Primary completion
2025-03
later than 1 of 17 live
Registered
40th of 50
by date

Among the 50 studies in Tibial Fractures with a site in United States, this one is the 10th largest by planned enrollment of the 12 observational ones that give a count, is one of 5 that started in 2021, is one of 12 observational ones, reaches primary completion later than 1 of the 17 other live ones, and was the 40th registered.

Tibial Fractures

136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.

Browse Tibial Fractures studies →

Open to participants now

15 of the 50 studies in Tibial Fractures with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 27 Tibial Fractures studies recruiting now, 13 (48%) set no upper age limit and 7 (26%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Tibial Fractures with a site in United States, or all of them as a file.
02

Study summary

This project consists of a prospective case design. Study candidates will include all patients ages 18 and over who were evaluated at UCSD and found to have a critical-sized humerus, femur, or tibia segmental defect that would be fixed through surgery. Patients who consent to study participation will receive the TRUMATCH Graft Cage for their long bone segmental defect repair. Data on healing rates, complication rates, re-operation rates, time to return to normal activity, and pain levels will be collected for each participation. After 3 years of data collection, we will analyze this data to provide further insight on the utility of the TRUMATCH Graft Cage. Given the significant difficulty with repairing segmental long bone defects, it is imperative to evaluate novel systems to appropriately manage these injuries.

03

Conditions studied

  • Tibia Fracture
  • Humerus Fracture
  • Femoral Fracture
  • Long Bone Segmental Defect
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients 18 years or older presenting to UCSD Medical Center with a humerus, femur, or tibia segmental defects requiring surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Humerus, femur, or tibia segmental defects requiring surgery
  • Evaluation and treatment at UCSD
  • Ages 18 year and older
  • Abiltiy to understand the content of the patient information/ form

Exclusion criteria

Exclusion Criteria:

  • Any not medically managed severe systemic disease
  • Their doctor has decided that it is in the patient's best interest to receive a different method of repair
  • Their doctor has determined that the patient has a condition that would make them unsuitable for participation in the study
  • Pregnancy or women planning to conceive within the subject participation period (1 year) note: pregnancy will be self-reported and no test will be performed to test for it
  • Prisoner
  • Participation in any other pharmacologic or medicinal product study within the previous month that could influence the results of this study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
5 participants (estimated)
Patient registry
No

Interventions

  • ProcedureTRUMATCH Graft Cage

    TRUMATCH Graft Cage for surgical repair of segmental long bone defect

06

What researchers measure

Primary outcomes

  1. Use of the TRUMATCH Graft Cage- Long Bone

    Time frame: 2 years

Secondary outcomes

  1. Healing Rates

    Time frame: 2 years

  2. Reoperation Rates

    Time frame: 2 years

  3. Complications

    Time frame: 2 years

  4. Pain Scores

    Time frame: 2 years

  5. Time to Return to Normal Activity

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2021 to primary completion in Mar 2025, 45 months.

Of 17 observational studies under Tibial Fractures, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 33 and three quarters within 62. This study's 45 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2022
First posted
Dec 29, 2022
StartActual
Jun 29, 2021
Primary completionActual
Mar 31, 2025
CompletionEst.
Jun 29, 2026
Last update
Feb 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05668182
Responsible party
William Kent (Assistant Professor of Orthopaedic Surgery, University of California, San Diego) — Principal investigator
First posted
Dec 29, 2022
Start date
Jun 29, 2021
Primary completion
Mar 31, 2025
Completion
Jun 29, 2026 (estimated)
Last update
Feb 9, 2026

Study contacts

Dominic Baun, MS
Contact
jbaun@health.ucsd.edu
858-534-8268
William Kent, MD
Contact
wkent@health.ucsd.edu
619-543-2694

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion